Fentanyl Information Sheet - Drugwatch

Latest

Medical Cannabis - what we've learnt from our membership

As anyone who reads this will already be aware there is currently an immense groundswell of interest from medical professionals, patients and the general public in the use of medical cannabis for many chronic conditions that are also prevalent in people who use alcohol and other drugs.
Annual General Meeting

2019 Annual General Meeting
POST-IT FROM PRACTICE: “But I’ve been on them for years, Doc”

Dr Steve Brinksman reflects on the increase of prescribed opioid pain killers and the potential thorny issue of de-prescribing.
FREE WEBINAR - Medical Cannabis and Anxiety with Dr Dani Gordon.

Tuesday 22.10.19 at 7 pm

Clinical Guidelines (2017) - "Orange Book"

Drug Misuse and Dependence - UK Guidelines on Clinical Management. 2017 edition.
Safer Prescribing in Prisons – 2nd Edition January 2019

The second edition of Safer Prescribing in Prisons has drawn on emerging evidence and responded to feedback from the first edition.
Guidance for the use and reduction of misuse of benzodiazepines

Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice by Drs Chris Ford and Fergus Law.
Supporting nurse mentors to reduce the barriers to implementing alcohol interventions and brief advice (IBA) in primary care
Naloxone supply protocol

Naloxone is a drug which temporarily reverses the effects of opioids such as heroin, methadone and morphine.
The Management of Pain in People with a Past or current history of addiction

Guidance on how to treat or manage pain in the context of a current addiction or an early, or even established recovery.
Misuse of synthetic opiods - NEPTUNE Expert Group

The misuse of synthetic opioids: harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids. Information for clinicians.

FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field.
SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership.
What we do

SMMGP is a support network for anyone who works in the treatment sector with people who use alcohol and other drugs problematically or any addictive behaviours, and we provide our members with quality CPD. We have a strong background in primary care. Federation of Drug and Alcohol Practitioners (FDAP) is the professional register for people who work in the addiction treatment sector. FDAP is overseen by an Assessment Board from various respected educational institutions who offer courses in a
FDAP Practitioner Directory

Check here for a directory of FDAP members.
Jobs

Look for jobs within the sector.
FDAP Drug and Alcohol Professional Certificate
Free resources

Free learning available on our website, click for more information.
Hospital management of alcohol withdrawal: elective vs unplanned admission and detoxification

Clinical Update editor Tom Jones summarises a research paper and comments on the topic of hospital management of alcohol withdrawal.
Free recorded webinar: Long-acting buprenorphine in criminal justice settings: implications for services
Free Clinical Update: Special Edition

This clinical update focuses on Buvidal® (CAM2038), the new prolonged-release subcutaneous buprenorphine injection for opioid use disorder.

FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field. Read more

SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership. Read more